Tissue recovery · Immune-adjacent · Collagen
Regenerative & Healing Peptides
Support for tissue recovery, immune-adjacent peptides, and oral collagen — with clear evidence limits and Canadian regulatory context.
Detail pages coming soon Individual compound profiles will be published after clinical review.
Who this category is for
Patients asking about soft-tissue recovery, post-training repair narratives, immune-adjacent peptide discussions, or nutritional collagen — often after orthopaedic, sports, or wellness consults. Online marketing for “healing peptides” frequently outruns the human evidence; our job is to separate labelled / nutritional options from experimental injectables.
How this differs from GH-axis or metabolic peptides
Regenerative conversations focus on local tissue signalling and repair themes (and, for collagen, nutritional support), not appetite hormones or pituitary GH pulses. Some muscle-maintenance education articles mention BPC-157 and TB-500 alongside GHS agents; we keep them here because their proposed mechanisms are recovery/tissue-oriented, and because human data remain limited.
Compounds on the Tri-Health education menu
| Compound | Evidence tier | Notes |
|---|---|---|
| BPC-157 | D–C | Popular recovery peptide; human evidence limited; appears in unauthorized injectable advisories |
| TB-500 / Thymosin β4 | D–C | Fragment marketing differs from ophthalmic Tβ4 trial literature; WADA considerations for athletes |
| Thymosin Alpha-1 | B–C | International immune-modulator history; verify current Canadian status before assuming availability |
| KPV | D | Preclinical inflammation models; limited human data |
| Collagen Peptides | B–C | Oral nutritional / NHP lane — not an injectable research peptide |
Safety snapshot
What we watch for
Contamination and mislabelling of unauthorized injectables; infection risk; unknown long-term safety; athlete anti-doping status for thymosin-related agents; unrealistic “heal anything” claims.
Tri-Health approach
Start with diagnosis, load management, physiotherapy, and nutrition. Discuss peptides only with evidence honesty, consent, and lawful sourcing. Oral collagen, when appropriate, is framed as nutrition — not as an injectable “research compound.”
How Tri-Health approaches regenerative peptides
- Clarify the injury or goal — imaging and rehab plan first when indicated.
- Explain evidence tiers plainly (most agents here are C–D for systemic injectable use).
- Screen medications, conditions, and sport testing status.
- Refuse RUO vial supervision; use licensed channels if a therapy proceeds.
- Reassess function and stop if benefit/risk is unclear.
See also: GH Secretagogues for recovery-adjacent GH-axis agents, and the Peptides 101 hub for Canadian regulation basics.
Book a peptide therapy consult
(905) 605-9355